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INTRODUCTION
Since the original description by Norum and Gjone
in 1967 (1), only 14 families with hereditary leci-
thin : cholesterol acyltrasferase (LCAT) deficiency
have been reported in Japan. This rare disease is
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Abstract : Lecithin : cholesterol acyltrasferase (LCAT) plays a key role in the cholesterol
metabolism-mediated esterification of free cholesterol into the cholesterol ester in normal
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and physiological techniques, the erythrocytes of this patient were investigated to gain an
insight into the relationship between the abnormalities of lipid metabolism and erythro-
cyte membrane fragility. Abnormal erythrocytes, so-called Target cells and/or Knizocytes,
were observed at 20% in our patient’s erythrocytes. Moreover, the mean corpuscular vol-
ume of the patient’s cells was 7% greater than that of a normal individual. In themembrane
lipids of the patient’s erythrocytes, cholesterol and phosphatidylcholine increased, and
phosphatidylethanolamine decreased. The electron spin resonance technique with a fatty
acid spin probe showed that the membrane fluidity was more elevated than that of normal
cells in spite of the increase in cholesterol content and the cholesterol/ phospholipid ratio
of the membrane of patient’s erythrocytes. The patient’s abnormally shaped erythrocytes
were less deformed than those of the normal individual under high shear stress. The par-
tial depletion of membrane cholesterol from the patient’s erythrocytes was demonstrated
by incubation with normal plasma with LCAT activity. The increment of transformed eryth-
rocytes during the incubation could be prevented by cholesterol depletion from the patient’s
erythrocyte membrane. These findings indicate that normochromic anemia of the patient
might be caused by erythrocyte fragility resulting from decreased deformity and/or abnor-
mal shape of the cells due to abnormal lipid composition in the membrane.
J. Med. Invest. 49 : 147-155, 2002
Keywords : familial lecithin : cholesterol acyltrasferase deficiency, cholesterol, osmotic fragility, membrane flu-
idity, erythrocyte deformability.
Abbreviations : LCAT ; lecithin : cholesterol acyltrasferase, the
CE/TC ratio ; the cholesterol ester/total cholesterol ratio, the
C/P ratio ; the free cholesterol/total phospholipids ratio, HDL ;
high density lipoprotein, ESR ; electron spin resonance, I(5.10) :
a stearic acid analogue of spin probe
Received for publication July 18, 2002 ; accepted July 31,
2002.
Address correspondence and reprint requests to Yutaka Nakaya,
M.D., Department of Nutrition, The University of Tokushima
School of Medicine, Kuramoto-cho, Tokushima 770-8503, Japan
and Fax : +81-88-633-7113.
The Journal of Medical Investigation Vol. 49 2002
１４７
manifested by moderate anemia, proteinuria and
corneal opacity (2-5). The proportion of cholesterol
esters in the total plasma cholesterol is invariably
depressed, although total cholesterol concentration
may either be depressed or elevated. It is also known
that cholesterol accumulates in a limited number
of organs in patients with genetic or secondary LCAT
deficiencies (6, 7), and erythrocytes are one of the
primary organs where such cholesterol accumula-
tion takes place.
LCAT specifically converts free cholesterol and
phosphatidylcholine into cholesterol esters and
lysophosphatidylcholine, respectively (8). Further-
more, this conversion is an irreversible reaction in
plasma as follows : membrane free cholesterol ← - - →
plasma free cholesterol - - → plasma cholesterol es-
ter. Hence its deficiency impairs the transport of
cholesterol from extrahepatic tissues to the liver via
plasma cholesterol esters. The resulting changes of
membrane lipids and/or erythrocyte shape are then
presumed to be responsible for the instability of the
patient’s erythrocytes with mechanical strain in cir-
culation. In this report, we examined a typical case
of this disease emphasizing the role of membrane
lipids in the physical properties of the erythrocytes.
Contrary to the above presumption, the patient’s
erythrocytes exhibited decreased osmotic fragility,
and increased membrane fluidity and visco-elasticity
despite the fact that the majority of the cells were
transformed, presumably owing to the abnormal
intramembrane distribution of lipid components as
a result of the lipid equilibrium.
Case presentation :
A 31-year-old woman exhibited the typical symptoms
of LCAT deficiency, such as anemia, proteinuria and
corneal opacity, but showed no liver or renal dys-
functions. She had been well until her visit and her
family history is summarized in Fig. 1. Hematocrit
was 32.7 percent ; red-cell count 3.29×106 per cubic
millimeter, white-cell count 8,100 per cubic millimeter,
and platelet count 200,000 per cubic millimeter. The
blood levels of total cholesterol was 96 mg/dL, tri-
glyceride 204 mg/dL, HDL-choesterol 13 mg/dL, to-
tal bilirubin 1.7 mg/dL, total protein 7.7 g/dL, aspartate
aminotransferase 20 IU, alanine aminotransferase
26 IU, alkaline phosphatase 191 IU and creatine kinase
111 IU. LCAT activity was 30% of the control. In-
formed consent was obtained from the patient and
her family.
Fresh blood was drawn by venipuncture into a
heparinized tube, and erythrocytes were washed twice
with an isotonic phosphate buffer containing 42.6
mM Na2HPO4, 7.2 mM NaHPO4. 5.1 mM KCl, 90.3
mM NaCl and 5.6 mM D-glucose, pH 7.4. The cells
were kept at 4 ℃.
Lipid and protein analysis
Lipids were extracted from the plasma and eryth-
rocyte membrane with 10 volumes of CHCl3-methanol
(2/1 by volume). Plasma cholesterol was measured
by the colorimetric method, and that in the eryth-
rocyte membrane was determined by gas chroma-
tography as described previously (9, 10). Phospholipid
compositions were analyzed by two dimensional thin
layer chromatography with Silica-Gel H (Merk Co.
Fig. 1. Pedigree of familial LCAT defi-
ciency. Arrow indicates proband. Circles
denote female subjects ; squares denote
male subjects. Arrows indicate proband,
and diagonal lines indicate deceased sub-
jects. At the top left of the symbols, the
cause of death is indicated, i.e., C indicates
cardiovascular disease , O other
diseases, ? unknown cause. In the sym-
bols, black represents subjects with typical
LCAT deficiency (LCAT activity>39% of
normal), black and white represents par-
tial deficiency (LCAT activity 40-60% of
normal), and white indicates unaffected
subjects. ＊indicates patients who were not
studied.
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Whitehouse Station, NJ), which was developed with
CHCl3-methanol-glacial acetic acid-water (25/15/4/2)
and CHCl3-methanol-28% ammonia-water (120/15/
4/2) as the first and second developing solvents, re-
spectively. The fatty acids of the membrane phospholipids
were analyzed by gas chromatography after being
esterified with 10% HCl-methanol (Tokyo Kasei Co.,
Tokyo, Japan) Lecithin : cholesterol acyltransferase
activity was determined using a commercial test kit
(Daiichi Chemicals Co, Ltd Tokyo, Japan) (11).
Scanning electron microscopy
Erythrocytes of the patient and a normal individ-
ual (33-year-old man) were fixed with 1% glutaraldehyde
and 1% OsO4, and successively dehydrated with etha-
nol. Then, the specimen was coated with Pt using
an Ion Coater (Model IB-5, Eiko Engineering., Tokyo,
Japan) and observed with a scanning electron micro-
scope (Model S-500, Hitachi Co. Tokyo, Japan).
Effect of membrane cholesterol depletion
In order to investigate the relationship between
membrane cholesterol and the erythrocyte shapes
of the patient, the cells were incubated with normal
plasma with LCAT activity (12). The erythrocytes
were diluted to 10% Ht, with plasma containing Peni-
cillin G (1000 units/ml) as a sterile drug, and incu-
bated for six hours at 37℃. After incubation, the test
tubes were centrifuged to remove the plasma, and
the lipids and hemoglobin were measured. Over
six hours, no hemolysis could be detected by the
cyanmethemoglobin method. Cells were washed
twice with isotonic buffer to analyze the membrane
lipids and to observe the erythrocyte shapes.
Membrane fluidity measurement
A stearic acid analogue of spin probe, 2-(10-carboxydecyl)-
2-hexyl-4, 4’-dimethyl-3-oxazolidinyloxyl, was pur-
chased from Syva Co. (Palo Alto. CA). The spin probe
was incorporated into intact erythrocyte membranes
by labeled albumin as described previously (8). The
labeled cells were packed in a capillary tube, and
electron spin resonance (ESR) spectra were recorded
by a Varian E-3 spectrometer at various tempera-
tures.
Measurement of erythrocyte deformability and osmo-
tic fragility
The cells were suspended in isotonic buffer with
20% Dextran T-40 (Pharmacia Chemical Co., Peapack,
NJ) and erythrocyte deformability was measured
using a rheoscope at 24℃. The ratio of long to short
axis lengths was measured as the deformation in-
dex. To measure osmotic fragility, the continuous
dilution method by Maeda et al . (13) was employed,
and salt concentrations giving 50% hemolysis and a
slope of 25% and 75% hemolysis were subsequent-
ly measured.
RESULTS
Hematological examination :
The hematological results are shown in Table 1,
Table 1. Hematological examinations of whole blood
Normal Individual LCAT deficiency
Red blood cells (×106/mm3)
Hematocrit (%)
Hemoglobin (g/dL)
Mean corpuscular volume
Mean corpuscular hemoglobin (pg)
Mean corpuscular hemoglobin concentration (%)
Reticulocytes (%)
Platelet (×104/mm3)
White blood cells (×103/mm3)
Neutorphils
Lymphocytes
Monocytes
Eosinophils
Basophils
Atypical lymphocytes
5.37 (4.98)
47.6 (45.5)
16.7
89 (91.5)
31.9
34.9
1.6
16.4
7.8
60.5
28.5
4.5
5.0
1.0
0.5
3.82 (3.80)
35.7 (38.0)
12.2
94 (100)
31.8
33.8
4.3
18.2
7.3
73.6
19.5
3.5
3.0
0.5
not detectable
Measurement by an Coulter Counter (Type A). Values by standard manual methods were given in paren-
thesises.
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in which the changes were mainly in erythrocytes.
The mean corpuscular volume increased by 7%. The
patient’s erythrocytes showed the typical figures of
normochromic anemia associated with increased
reticulocytes (4.3%). Moreover, the erythrocytes were
heterogeneous in shape and about one-fifth of the
cells were either so-called Target cells or Knizocytes
(Fig. 2).
Comparison of plasma and erythrocyte membrane
lipids :
The lipid composition of the patient’s plasma is
listed in Table 2. Plasma CE concentration was marke-
dly decreased in association with the decrease of
TC concentration. In our case, the CE/TC (choles-
terol ester/total cholesterol) ratio by weight was de-
creased to 0.31, whereas the normal value was 0.73.
Inversely, the cholesterol content in the erythrocyte
membrane of the patient was increased by 140% com-
pared with that of the normal individual (Table 3).
Although the changes in phosphatidylchone and
phosphatidylethanolamine concentrations in the plasma
were small, the difference in plasma total phospholipid
concentrations between the patient and the normal
subject was maintained (Table 2). The erythrocyte mem-
brane of the patient had increased phosphatidylchone,
and decreased phosphatidylethanolamine (Table 3)
in a type of equilibration of these phospholipids be-
Fig. 2. Schematic illustration of lipid equilibrium (upper panel) and the abnormal shapes of the lipid accumulated erythrocytes in
the patient’s membrane (lower panel).
Upper panel ; Cholesterol level of the erythrocyte membrane was estimated by the number of erythrocytes in the blood and cho-
lesterol per cell in the membrane. Dotted square indicates other compartments (such as cell membrane or lipoproteins). In a patient
with LCAT, cholesterol ester in the plasma was decreased but cholesterol of the erythrocyte membrane increased.
Lower panel ; Left, control subject. Right, LCAT deficiency subject (#1). Abnormal erythrocytes (Target cells) are indicated by arrow
heads. Note that the concavity of the cells was lost in Target cells. The white bar in the electron scanning microscope photographs
indicated the scale of 5 µm (Magnification × 2800).
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tween the plasma and erythrocyte membrane in the
patient’s blood. To obtain more quantitative figures, the
phospholipid content in the membranes was calculated
on the basis of moles of phospholipids per cell. The
phosphatidylchone content per cell in the patient’smem-
brane was 158%, whereas the phosphatidylethanolamine
content was 42% of that found in the membrane of
the normal individual. However, sphingomyelin and
phosphatidylserine in the patient’s membrane did
not differ. Overall, the ratio of free cholesterol to to-
tal phospholipids (C/P) was slightly increased in the
erythrocyte membrane of the patient to maintain the
lipid partition equilibrium.
Relationship of membrane cholesterol and cell shape :
When normal plasma containing LCAT was added
to the patient’s erythrocytes, the cholesterol content
in the patient membrane decreased, 3.74×10-16 moles
per cell associated with increase of cholesterol es-
ter concentration in the normal plasma (Table 4).
Namely, part of the membrane cholesterol of the pa-
tient’s erythrocytes moved to the plasma cholesterol
ester via plasma free cholesterol by LCAT reaction.
When authentic plasma or normal plasma with LCAT
inhibitor (iodoacetoamide ; 1 mM) was added to the
patient’s cells, no cholesterol movement from the mem-
brane occurred. While transformed cells were 28.7%
from the influence of long-term erythrocyte incuba-
tion of the normal subject, the transformed cells in-
creased from 19.9% to 49.5% in the patient with authen-
tic plasma. This marked increment of abnormal trans-
formation in the patient’s cells was held at 27.5% by
incubation with normal plasma instead of that of the
patient, which was similar to that of the normal sub-
ject. This suggested that the prevention of abnormal
transformation of the patient’s cells might attribute
to partial depletion of the membrane cholesterol.
Physical properties of the erythrocytes :
The patient’s erythrocyte exhibited marked osmot-
ic resistance. NaCl concentrations at 50% hemolysis
were 0.309±0.00 l% and 0.362±0.004% of NaCl equiva-
Table 2. Plasma lipid of the pateints and naormal individual
Normal individual LCAT deficiency
Total cholesterol (TC ; mg/dL)
Free cholesterol (mg/dL)
Cholesterol ester (CE ; mg/dL)
CE/TC
Phospholipids (mg/dL)
Phospholipids composition (%)
Lysophosphatidylcholine
Posphatidyliositol+Phsophatidylserine
Sphingomyelin
Phosphatidylethanolamine
Phosphatidylcholine
157
43
114
0.73
168
7.9±2.2
3.2±0.7
17.9±1.1
6.1±0.6
64.9±0.2
67
46
21
0.31
171
not detectable
not detectable
16.3
1.1
82.6
Table 3. Erythrocytes membrane lipids of the patient and normal individual
Normal individual LCAT deficiency
Cholesterol (C ; ×10-16mol/cell)
Phospholipids (P : ×10-16mol/cell)
C/P ratio
Phospholipids composition (mol ; %)
Lysophosphatidylcholine
Posphatidyliositol
Phsophatidylserine
Sphingomyelin
Phosphatidylethanolamine
Phosphatidylcholine
3.01±0.08
3.66±0.12
0.82
0.8±0.7 (0.03)
2.8±0.6 (0.10)
11.8±0.6 (0.43)
30.3±2.1 (1.11)
21.5±2.6 (0.79)
32.7±0.2 (1.21)
4.24±0.21
4.28±0.11
0
1.5±0.3 (0.06)
2.5±0.9 (0.11)
9.3±0.5 (0.40)
26.0±1.8 (1.11)
9.1±1.7 (0.39)
51.6±1.6 (2.21)
Values in the parenthesises were calculated from 3.66 and 4.28×10 -16moles/cell, respectively.
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lent in the patient’s and normal cells, respectively.
However, the other parameters of osmotic resistance
(H25 -75) were increased 1.75 fold in spite of the
high C/P ratio of the membrane.
The erythrocyte membrane fluidity of the patient
was assessed by ESR analysis using a lipid analogue.
The erythrocyte membrane gave a small but nar-
row overall splitting (2T//) between the outer ex-
tremes of the ESR spectrum (Fig. 3). This difference
was approximately two gausses at 17℃ (Fig. 3). When
the temperature dependence of the splitting was
examined, this difference was evident over the range
2℃ and to 39℃. Moreover, the discontinuity seen
with a normal membrane at 22℃ singularly disap-
peared in the patient’s membrane. The results sug-
gested that the erythrocyte membrane with LCAT
deficiency was more fluid in spite of its high cho-
lesterol content.
In order to examine the functional properties of
the patient’s erythrocytes, the deformability of the cells
was measured (Fig. 4). The decreased deformability
of the patient’s cells, which gave smaller values for
deformation indices than normal cells, might reflect
increased reticulocytes (4.3%) in the patient’s circu-
lation (Table 1).
DISCUSSION
Increased phosphatidylchone and cholesterol, and
decreased phosphatidylethanolamine in the patient’s
erythrocyte membrane (Table 3) are consistent with
earlier reports of LCAT deficiency. In our case, the
free cholesterol concentration in the plasma was
maintained to the normal concentration though the
cholesterol ester proportion was low due to LCAT
deficiency (Table 2). Inversely, the membrane cho-
lesterol (140%) and phospholipids (127%) in the pa-
tient’s cells were increased in spite of a decrease
of phosphatidylethanolamine (42%) as shown in
Table 3. In order to investigate the relation between
plasma and the membrane lipid of the patient, we
estimated the total amount of free cholesterol (6 l
mg/dl) in plasma and the erythrocytes in blood in
circulation. As a result, this value was unchanged
between the patient’s and normal blood. From the
above calculation, it was suggested that an equilib-
rium of cholesterol between the plasma and mem-
brane might exist and decline to the patient’s mem-
brane accompanied with increased phospholipids
and changes of the phospholipid compositions of the
membrane. Thus, membrane cholesterol accumulated
accompanied with changes of phosphatidylcholine and
phosphatidylethanolamine levels in the membrane.
Owing to abnormality in the membrane lipids, the
patient’s erythrocytes also exhibited increased mean
corpuscular volume, abnormal erythrocyte shapes,
and anemia associated with increased reticulocytes.
Concerning osmotic resistance in vitro , our previous
report (9, 13) showed that the C/P ratio of the mem-
Table 4. Relationship of membrane cholesterol and erythrocyte shapes
Erythrocyte
Lipids
Transformed
Erythrocytesc)
Plasma
Lipids
FCa) PLsa) C/Pb) FC/TCd) CE/TCd)
Normal subject’s erythrocytes
1) before incubation
2) incubation with normal plasma
3) incubation with patient plasma
4) incubation with normal plasma
and LCAT inhibitor
LCAT deficiency’s erythrocytes
1) before incubation
2) incubation with patient plasma
3) incubation with normal plasma
4) incubation with patient plasma
and LCAT inhibitor
3.15
2.79
3.21
3.22
4.15
4.22
3.74
4.23
3.80
3.87
3.77
3.76
4.33
4.33
4.32
4.38
0.83
0.72
0.85
0.86
0.96
0.97
0.91
0.97
3.4±0.4
28.7±6.1
25.6±8.7
echinocyte
19.5±10.0
49.5±11.2
27.5±9.1
echinocyte
33.5
29.3
67.6
33.7
70.6
69.1
28.9
70.2
66.5
70.7
32.4
66.3
29.4
30.9
71.1
29.8
a) All values were expressed as ×10-１６moles/cell.
b) All values were expressed as molar ratio.
c) All values were expressed as % and mean±S.D..
d) All values were expressed as weight %.
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brane was one of the factors which increased the
osmotic fragility. However, in this patient, another
parameter of osmotic fragility, H25-75, was increased
1.7 fold compared with that of the normal subject.
If the increased osmotic resistance was due to the
increased C/P ratio of the membrane, the other pa-
rameter would decrease followed by increased free
cholesterol in the membrane (9, 13, 16). Thus, the
change of osmotic fragility in the patient might sug-
gest other factors such as the increased surface area
of the membrane and/or mean corpuscular volume
due to lipid abnormality in the membrane. It has
been reported that erythrocytes with LCAT deficien-
cy possess a short life-span in vivo . It had been ac-
cepted that erythrocyte deformability was one of the
major factors in the destruction of circulation. We,
as well as other investigators, reported previously
that deformability, membrane fluidity and choleste-
rol content are closely related : that is, increased cho-
lesterol concentration in the erythrocyte membrane
decreases deformability due to the decreased mem-
brane fluidity of the cells (16). This patient’s cells,
however, possessed decreased deformability in spite
of elevated membrane fluidity. In 1997, Abugo et al .
showed that geometric properties such as mean cor-
puscular volume and excess surface area were re-
lated to the deterioration of the red cell mechanical
properties in capillary flow (17). In this case, the
amount of membrane lipids (free cholesterol and
total phosphpolipids) accumulated to 127% due to
(a)
(b)
Fig. 3. (a) Electron spin resonance spectra of I (5, 10)-labeled
erythrocytes.
(upper spectra) control, (lower spectra) LCAT deficien-
cy subject.
(b) Temperature dependence of the overall splitting
(gauss).
(●) control, (▲) LCAT deficiency subject
Fig. 4. Viscosity (upper panel) and deformability of erythrocytes
(lower panel) under various shear rates. Viscosity and
deformability of patient’s erythrocytes were decreased
compared to those of a normal subject.
(●) control, (▲) LCAT deficient subject
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the deterioration of lipid equilibrium. Therefore, the
abnormal shape of the patient’s erythrocytes was
related to the depletion of the partial free choleste-
rol by LCAT from the patient’s membrane followed
by decreased abnormal shapes in vitro in Table 4.
The total lipid amount of free cholesterol and
phosphpolipids increased by 27% associated with the
completely different phospholipid compositions. The
increased phosphatidylchone (158%) and decreased
phosphatidylethanolamine (42%) in the membrane
might contribute to the increased fluidity of the pa-
tient’s membrane in spite of the slight increase in
C/P ratio.
Recently, Jain et al . (18) indicated that a patient’s
erythrocytes were more unstable mechanically in
hypotonic medium due to membrane fragmentation
of the cells, and were more susceptible to peroxidant
stress due to the increased membrane level of poly-
unsaturated fatty acid. In our case, the fatty acid com-
positions of phospholipids in the membrane did not
change significantly (data not shown). On the other
hand, Flamm K and Schacter D (19) showed that
erythrocyte membranes with betalipoprotein deficiency
and enriched membrane cholesterol decreased the
fluidity of the outer but not the inner hemileaflet. It
is interesting that erythrocyte membranes (acanthocytes)
with betalipoprotein deficiency have increased cho-
lesterol and phosphatidylethanolamine, but decreased
phosphatidylchone, which is opposite to those changes
in LCAT deficiency.
Concerning the asymmetric distribution of mem-
brane phospholipids as a sort of lipid equilibrium,
membrane proteins such as spectrin play an impor-
tant role in the maintenance of membrane lipid asym-
metry in erythrocytes (20, 21). The membrane pro-
teins of our patient did not reveal any abnormalities
(data not shown).
These results suggest that erythrocytes with LCAT
deficiency may have an abnormal intramembrane
distribution of lipids, and abnormal properties such
as deformability, membrane fluidity, mean corpus-
cular volume and the shape of the cells may attrib-
ute to the abnormal distribution of membrane lipids.
This was supported by the fact that we are able
to prevent the increase of transformed cells by means
of cholesterol depletion from the membrane (Table 4).
As a preliminary experiment for confirmation, intact
erythrocyte membranes were exposed to choleste-
rol oxidase from outside the membrane. Although
all the membrane cholesterol was oxidized, choles-
terol in the patient’s membrane exhibited less re-
activity (ca. 4 fold) despite the total amount of cho-
lesterol being richer than in normal cells. These re-
sults indicate that anemia, abnormal shape and the
increased mean corpuscular volume of this patient’s
erythrocytes may be related to membrane instabil-
ity owing to the abnormal distribution of membrane
lipids such as cholesterol, phosphatidylcholine and
phosphatidylethanolamine.
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